Your browser doesn't support javascript.
loading
Fufang-zhenzhu-tiaozhi formula protects islet against injury and promotes ß cell regeneration in diabetic mice.
Chen, Xu; Yin, Jianying; Zhong, Qin; Wang, Ke; Zhang, Xiaoyu; Liang, Mingjie; Lin, Quanyou; Wang, Hong; Wang, Weixuan; Wang, Lexun; Hu, Xuguang; Bei, Weijian; Guo, Jiao.
Afiliação
  • Chen X; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Yin J; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Zhong Q; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Wang K; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Zhang X; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Liang M; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Lin Q; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Wang H; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Wang W; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Wang L; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Hu X; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Bei W; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
  • Guo J; Key Laboratory of Glucolipid Metabolic Disorder of Ministry of Education, China; Key Unit of Modulating Liver to Treat Hyperlipemia SATCM (State Administration of Traditional Chinese Medicine), China; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, China; Guan
J Ethnopharmacol ; 301: 115791, 2023 Jan 30.
Article em En | MEDLINE | ID: mdl-36240976
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Metformina Limite: Animals Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Metformina Limite: Animals Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2023 Tipo de documento: Article